Membrane Permeability of Acylated Cystatin Depends on the Fatty Acyl Chain Length

Hydrophobization of proteins, such as chemical acylation, has been recognized as an efficient method for improving their membrane permeability. In this research, chicken cystatin, a model protein inhibitor of cysteine proteinases, was acylated with fatty acyl residues of 6–18 carbon atoms. The chemical modification was performed using fatty acyl chloride dispersion in aqueous acetonitrile solution. The reaction products were analyzed by capillary electrophoresis, SDS‐PAGE and isoelectric focusing. In vitro inhibitory activity was determined by N‐benzoyl‐d,l‐arginine‐β‐naphthylamide assay and membrane permeability properties of non‐acylated and acylated cystatin by measuring its efficiency to inhibit intracellular cathepsin B in MCF‐10A neo T cells. The experiments showed that acylated cystatin quickly internalized into the cells and effectively inhibited cathepsin B. In contrast, non‐acylated cystatin did not cause inhibition as it was unable to enter the cell. The permeability enhancement effect was shown to depend on the length of the attached fatty acyl chain as the strongest inhibition was caused by cystatin acylated with stearoyl chloride. In addition, chemical modification did not influence the protein’s immunogenicity.

[1]  J. M. Dow,et al.  The Acylation and Phosphorylation Pattern of Lipid A from Xanthomonas Campestris Strongly Influence its Ability to Trigger the Innate Immune Response in Arabidopsis , 2008, Chembiochem : a European journal of chemical biology.

[2]  B. Ryffel,et al.  Acylation Determines the Toll-like receptor (TLR)-dependent Positive Versus TLR2-, Mannose Receptor-, and SIGNR1-independent Negative Regulation of Pro-inflammatory Cytokines by Mycobacterial Lipomannan* , 2007, Journal of Biological Chemistry.

[3]  O. Jensen,et al.  Characterization of N-palmitoylated human growth hormone by in situ liquid-liquid extraction and MALDI tandem mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[4]  J. Kos,et al.  Improved Acylation Method Enables Efficient Delivery of Functional Palmitoylated Cystatin into Epithelial Cells , 2007, Chemical Biology and Drug Design.

[5]  N. Ueno,et al.  Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. , 2006, Developmental cell.

[6]  M. Resh,et al.  Trafficking and signaling by fatty-acylated and prenylated proteins , 2006, Nature chemical biology.

[7]  J. Kos,et al.  Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  A. Kabanov,et al.  New technologies for drug delivery across the blood brain barrier. , 2004, Current pharmaceutical design.

[9]  R. Deschenes,et al.  New insights into the mechanisms of protein palmitoylation. , 2003, Biochemistry.

[10]  L. Wan,et al.  Site-Specific Lipophilic Modification of Interferon-α , 2002 .

[11]  J. Kos,et al.  Invasion of ras-Transformed Breast Epithelial Cells Depends on the Proteolytic Activity of Cysteine and Aspartic Proteinases , 2001, Biological chemistry.

[12]  W. Shen,et al.  Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformation in cultured mouse mammary glands. , 2001, Cancer letters.

[13]  J. Kos,et al.  Cysteine Proteinases and Their Inhibitors in Extracellular Fluids: Markers for Diagnosis and Prognosis in Cancer , 2000, The International journal of biological markers.

[14]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[15]  Magdassi,et al.  Chemically Modified Human Immunoglobulin G: Hydrophobicity and Surface Activity at Air/Solution Interface. , 1999, Journal of colloid and interface science.

[16]  L. Fenart,et al.  Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[17]  J. Kos,et al.  Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.

[18]  S. Attah-poku,et al.  Palmitoyl derivatives of interferon α: Potential for cutaneous delivery , 1998 .

[19]  C. Ambrose,et al.  Identification of a Palmitic Acid-modified Form of Human Sonic hedgehog* , 1998, The Journal of Biological Chemistry.

[20]  Cornelis J. F. Van Noorden,et al.  Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B , 1998, Clinical & Experimental Metastasis.

[21]  S. Havelund,et al.  Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue. , 1997, Journal of pharmaceutical sciences.

[22]  Magdassi,et al.  Adsorption of Hydrophobized Glucose Oxidase at Solution/Air Interface , 1997, Journal of colloid and interface science.

[23]  J. Wang,et al.  Comparison of Pharmacokinetic Parameters of a Polypeptide, the Bowman-Birk Protease Inhibitor (BBI), and Its Palmitic Acid Conjugate , 1996, Pharmaceutical Research.

[24]  S. Magdassi,et al.  Formation and properties of horseradish peroxidase colloidal clusters , 1996 .

[25]  K. Hazen,et al.  Aggregation of hydrophobic cell wall proteins of Candida albicans , 1995 .

[26]  A. R. Kennedy,et al.  Water‐soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides , 1995, FEBS letters.

[27]  V. Slepnev,et al.  Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells. , 1995, Bioconjugate chemistry.

[28]  R. Locksley,et al.  Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues , 1992, The Journal of experimental medicine.

[29]  M. Cruz,et al.  Acylation of L-asparaginase with total retention of enzymatic activity. , 1990, Biochimie.

[30]  V. Alakhov,et al.  Increasing cytostatic effects of ricin A chain and Staphylococcus aureus enterotoxin A through in vitro hydrophobization with fatty acid residues , 1990, Biotechnology and applied biochemistry.

[31]  J. Kos,et al.  The cysteine proteinase inhibitor chicken cystatin is a phosphoprotein , 1989, FEBS letters.

[32]  W. Bode,et al.  The 2.0 A X‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. , 1988, The EMBO journal.

[33]  V. Torchilin,et al.  Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane. , 1980, Biochimica et biophysica acta.

[34]  J. Folch,et al.  Proteolipides, a new type of tissue lipoproteins; their isolation from brain. , 1951, The Journal of biological chemistry.

[35]  L. Wan,et al.  Site-specific lipophilic modification of interferon-alpha. , 2002, Journal of protein chemistry.

[36]  S. Attah-poku,et al.  Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery. , 1998, Journal of pharmaceutical sciences.

[37]  J. Kos,et al.  Isolation and characterisation of chicken L- and H-kininogens and their interaction with chicken cysteine proteinases and papain. , 1992, Agents and actions. Supplements.

[38]  A. Ladhoff,et al.  Incorporation of chemically modified (hydrophobized) ferritin in liposomal membranes: electron microscopic studies. , 1984, Biomedica biochimica acta.

[39]  B. Smith,et al.  SDS Polyacrylamide Gel Electrophoresis of Proteins. , 1984 .